Differential prognostic impact of liver resection by the site of concurrent extrahepatic diseases in patients with colorectal cancer liver metastases: a nationwide multicenter study
Authors:
- Hirochika KatoHKHirochika Kato
- Ryo SeishimaRSRyo Seishima
- Jun OkuiJOJun Okui
- Kohei ShigetaKSKohei Shigeta
- Yasunori SatoYSYasunori Sato
- Shin KobayashiSKShin Kobayashi
- Katsunori SakamotoKSKatsunori Sakamoto
- Hirotoshi KobayashiHKHirotoshi Kobayashi
- Kazushige KawaiKKKazushige Kawai
- Kimitaka TaniKTKimitaka Tani
- Yoichi AjiokaYAYoichi Ajioka
- Itaru EndoIEItaru Endo
Open Access
- 13 June 2025
- journal article
- research article
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 111 (9) , 5893-5903
Abstract
Background: Liver resection for colorectal liver metastases (CRLM) with concurrent extrahepatic disease (EHD) has demonstrated potential benefits for long-term prognosis; however, its effectiveness remains controversial. Additionally, the prognostic impact of different EHD sites is not well elucidated. This study aimed to assess the significance of liver resection in patients with CRLM with concurrent EHD and evaluate how different EHD sites influence prognosis. Methods: A nationwide multicenter database was used for a retrospective analysis of patients diagnosed during two periods: 2005–2007 and 2013–2015. EHD was classified into the following five subgroups: lung, peritoneum, lymph nodes, local, and others. The inverse probability of treatment weighting (IPTW) method was applied to minimize selection bias. Kaplan–Meier survival curves and Cox proportional hazards models were used to compare the overall survival (OS) between the different treatment groups and EHD subgroups. Results: Among 3787 patients, 874 (23.1%) underwent liver resection. Following IPTW adjustment, the hepatectomy (HT) group demonstrated significantly better OS than the non-hepatectomy (non-HT) group (5-year hazard ratio, 0.322; 95% confidence interval, 0.273–0.379; P < 0.001). Analysis by the EHD site subgroup demonstrated that liver resection was associated with a better prognosis across all sites. However, the prognostic impact differed by EHD site, with peritoneal metastasis associated with poorer outcomes in both the HT (5-year OS rates, 30.1% vs. 45.0%) and non-HT (5-year OS rates, 4.4% vs. 8.6%) groups. Conclusions: Regardless of the EHD site, liver resection was associated with a significantly better OS in patients with CRLM with concurrent EHD. The prognostic impact varies across EHD sites, underscoring the significance of considering differential prognostic risks when selecting treatment strategies.Keywords
This publication has 35 references indexed in Scilit:
- Rates and Patterns of Recurrence Following Curative Intent Surgery for Colorectal Liver MetastasisAnnals of Surgery, 2009
- Liver resection for metastatic colorectal cancer in the presence of extrahepatic diseaseThe Lancet Oncology, 2009
- Liver Resection for Metastatic Colorectal Cancer in Patients with Concurrent Extrahepatic Disease: Results in 127 Patients Treated at a Single CenterAnnals of Surgical Oncology, 2009
- Complete Cytoreductive Surgery Plus Intraperitoneal Chemohyperthermia With Oxaliplatin for Peritoneal Carcinomatosis of Colorectal OriginJournal of Clinical Oncology, 2009
- Evaluation of Long-term Survival After Hepatic Resection for Metastatic Colorectal CancerAnnals of Surgery, 2008
- Surgical Resection of Colorectal Liver Metastases in Patients with Expanded Indications: A Single-Center Experience with 501 PatientsDiseases of the Colon & Rectum, 2007
- Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver MetastasesAnnals of Surgery, 2004
- Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal CancerJournal of Clinical Oncology, 2003
- Clinical Score for Predicting Recurrence After Hepatic Resection for Metastatic Colorectal CancerAnnals of Surgery, 1999
- Survival in patients with large-bowel cancerDiseases of the Colon & Rectum, 1990